Induction of Quinone Reductase and Glutathione Transferase in Rat Tissues by Juglone and Plumbagin

Abstract

The ability of the naturally-occurring naphthoquinone derivatives, juglone and plumbagin, to increase tissue activities of the Phase II detoxification enzymes quinone reductase (QR) and glutathione transferase (GT) has been investigated in rats. Groups of female Sprague-Dawley rats were dosed by oral intubation on 5 consecutive days with either juglone or plumbagin at 12.5, 25, 50, 75, 100 or 125 μmoles/kg/day. The animals were then killed and the activities of QR and GT determined in tissue homogenates. The naphthoquinone derivatives had no significant effect on enzyme activities in the liver, spleen, heart, lung or urinary bladder. Increases in the activities of one or both enzymes were recorded, however, in the caecum, kidney, forestomach, duodenum, colon, glandular stomach and jejunum. The possibility that induction of Phase II enzymes could contribute to the previously-reported ability of juglone and plumbagin to protect animals against chemically-induced intestinal neoplasia is discussed.

Key words

Juglone - plumbagin - quinone reductase - glutathione transferase - naphthoquinones - chemoprevention - Juglandaceae - Plumbaginaceae - Droseraceae

References

• 1 Thomson  R.. Naturally Occurring Quinones, 2nd edn., Academic Press, London; 1971
• 2 Thomson  R H.. Naturally Occurring Quinones. III. Recent Advances. Chapman and Hall, London; 1987
• 3 Gujar  G T.. Fitoterapia. 1990;;  61 387-94
• 4 Kokwaro  J O.. Medicinal Plants of East Africa. East African Literature Bureau, Kampala; 1976
• 5 Watt  J M,, Breyer-Brandwijk  M G.. The Medicinal and Poisonous Plants of Southern and Eastern Africa, 2nd edn., Livingstone, Edinburgh; 1962
• 6 Talalay  P,, Fahey  J W,, Holtzclaw  W D,, Prestera  T,, Zhang  Y.. Toxicol. Lett.. 1995;;  82/83 173-9
• 7 Begleiter  A,, Leith  M K,, Curphey  T J,, Doherty  G P.. Oncol. Res.. 1997;;  9 371-82
• 8 Kensler  T W.. Environ. Health. Perspect.. 1997;;  105, Suppl. 4 965-70
• 9 Wattenberg  L W.. Proc. Soc. Exp. Biol. Med.. 1997;;  216 133-41
• 10 Sugie  S,, Okamoto  K,, Wahidur Rahman  K M,, Tanaka  T,, Kawai  K,, Yamahara  J,, Mori  H.. Cancer Lett.. 1998;;  127 177-83
• 11 Teuber  H-J,, Götz  N.. Chem. Ber.. 1954;;  87 1236-51
• 12 Ernster  L.. Meth. Enzymol.. 1967;;  10 309-17
• 13 Habig  W H,, Pabst  M J,, Jakoby  W B.. J. Biol. Chem.. 1974;;  249 7130-9
• 14 Auyong  T.. Proc. Soc. Exp. Biol. Med.. 1968;;  127 585-7
• 15 Iyengar  M A,, Pendse  G S.. Planta Med.. 1966;;  14 337-51
• 16 Munday  R,, Munday  C M.. Nutr. Cancer. 1999;;  34 42-8
• 17 Reddy  B S,, Rao  C V,, Rivenson  A,, Kelloff  G.. Cancer Res.. 1993;;  53 3493-8
• 18 Wargovich  M J,, Chen  C-D,, Jimenez  A,, Steele  V E,, Velasco  M,, Stephens  C,, Price  R,, Gray  K,, Kelloff  G J.. Cancer Epidemiol. Biomark. Prev.. 1996;;  5 355-60
• 19 Tanaka  T,, Kawabata  K,, Kakumoto  M,, Makita  H,, Matsunaga  K,, Mori  H,, Satoh  K,, Hara  A,, Murakami  A,, Koshimizu  K,, Ohigashi  H.. Jap. J. Cancer Res.. 1997;;  88 821-30
• 20 McLellan  E,, Bird  R P.. Carcinogenesis. 1991;;  12 969-72
• 21 Rao  C V,, Rivenson  A,, Kelloff  G J,, Reddy  B S.. Anticancer Res.. 1995;;  15 1199-204
• 22 Vargas  M,, Lamb  J G,, Franklin  M R.. Drug Metab. Disp.. 1998;;  26 91-7
• 23 Prochaska  H J,, Fernandes  C L.. Carcinogenesis. 1993;;  14 2441-5
• 24 Ansher  S S,, Dolan  P,, Bueding  E.. Food Chem. Toxicol.. 1986;;  24 405-15